1-3 of 3
Eric N. Van Roon
Close
Sort by
Journal Articles

Monitoring of Plasma Ferritin Levels after Blood Transfusions in Patients with Myelodysplastic Syndromes

Johanne Rozema, Ivar Van Asten, Beau Kwant, Robby E Kibbelaar, Nic J.G.M. Veeger, Harry De Wit, Eric N. Van Roon, Mels Hoogendoorn
Journal: Blood
Blood (2021) 138 (Supplement 1): 1986.
https://doi.org/10.1182/blood-2021-152096
Published: 2021
Journal Articles

Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study

Berdien Oortgiesen, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Robby Kibbelaar, MD PhD, Huib Storm, PhD, Sjoerd Hovenga, MDPhD, Bas P Van Rees, MD PhD, Gerhard Woolthuis, MD, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2136.
https://doi.org/10.1182/blood.V124.21.2136.2136
Published: 2014
Journal Articles

Prognostic Importance of Comorbidity in a Population-Based Analysis of Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

AndreĢ Wieringa, PharmD, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Tim Beerden, B.Sc, Huib Storm, PhD, Robby Kibbelaar, MD, PhD, Hanneke C. Kluin-Nelemans, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3656.
https://doi.org/10.1182/blood.V120.21.3656.3656
Published: 2012